Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Director departure
Appointed director
GeoVax Labs, Inc. (GOVX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/22/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/10/2023 8-K Quarterly results
Docs: "GeoVax Reports 2023 Second Quarter Financial Results and Provides Corporate Update"
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
07/18/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: " ",
" "
07/18/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
06/12/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
06/12/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
05/05/2023 8-K Quarterly results
Docs: "GeoVax Reports 2023 First Quarter Financial Results and Provides Corporate Update"
05/04/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/04/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/04/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/27/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
03/27/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/27/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/27/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/24/2023 8-K Quarterly results
Docs: "GeoVax Reports 2022 Year-End Financial Results And Provides Corporate Update"
03/23/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/23/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/23/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/23/2023 10-K Annual Report for the period ended December 31, 2022
12/09/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
12/08/2022 8-K Appointed a new director
Docs: "2023 Stock Incentive Plan",
"GeoVax Appoints Jayne Morgan, M.D., to its Board of Directors"
11/14/2022 8-K Quarterly results
Docs: "GeoVax Reports 2022 Third Quarter Financial Results and Provides Corporate Update",
"Conference Call Transcript",
"Conference Call Slide Presentation"
11/09/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
11/09/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
11/09/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
09/01/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "GeoVax Announces Addition to its Board of Directors"
09/01/2022 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits  Interactive Data
08/04/2022 8-K Quarterly results
Docs: "FINANCIAL TABLES FOLLOW MORE GEOVAX LABS, INC. Condensed Consolidated Statements of Operations Information",
"Conference Call Transcript",
"Conference Call Slide Presentation"
08/03/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/03/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy